Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Social Media | 4 | 2024 | 121 | 1.190 |
Why?
|
| Appendicitis | 2 | 2022 | 138 | 0.800 |
Why?
|
| Appendix | 1 | 2022 | 15 | 0.750 |
Why?
|
| Foreign Bodies | 1 | 2022 | 110 | 0.680 |
Why?
|
| Pathology, Clinical | 2 | 2017 | 20 | 0.680 |
Why?
|
| Biopsy, Fine-Needle | 3 | 2022 | 119 | 0.600 |
Why?
|
| Thyroid Nodule | 1 | 2017 | 22 | 0.530 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 133 | 0.510 |
Why?
|
| Confidentiality | 1 | 2016 | 106 | 0.470 |
Why?
|
| Rhabdomyoma | 1 | 2014 | 15 | 0.440 |
Why?
|
| Heart Neoplasms | 1 | 2014 | 104 | 0.400 |
Why?
|
| Physician-Patient Relations | 1 | 2016 | 448 | 0.370 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2014 | 275 | 0.360 |
Why?
|
| Communication | 1 | 2016 | 542 | 0.360 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 946 | 0.360 |
Why?
|
| Pathologists | 1 | 2024 | 26 | 0.220 |
Why?
|
| Sertoli-Leydig Cell Tumor | 1 | 2022 | 18 | 0.180 |
Why?
|
| Cytodiagnosis | 2 | 2022 | 20 | 0.180 |
Why?
|
| Ribonuclease III | 1 | 2022 | 99 | 0.180 |
Why?
|
| Lymphadenopathy | 1 | 2021 | 31 | 0.170 |
Why?
|
| Pyoderma Gangrenosum | 1 | 2020 | 4 | 0.170 |
Why?
|
| Histiocytosis, Sinus | 1 | 2021 | 33 | 0.170 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2022 | 127 | 0.170 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2021 | 61 | 0.170 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2022 | 146 | 0.170 |
Why?
|
| Skin Ulcer | 1 | 2020 | 32 | 0.170 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2020 | 10 | 0.160 |
Why?
|
| Sarcoma | 1 | 2022 | 207 | 0.160 |
Why?
|
| Orbit | 1 | 2020 | 84 | 0.150 |
Why?
|
| Granuloma | 1 | 2019 | 65 | 0.150 |
Why?
|
| Appendectomy | 1 | 2019 | 92 | 0.150 |
Why?
|
| Attitude of Health Personnel | 1 | 2024 | 724 | 0.150 |
Why?
|
| Malnutrition | 1 | 2020 | 161 | 0.140 |
Why?
|
| Bone Neoplasms | 1 | 2022 | 444 | 0.140 |
Why?
|
| Professionalism | 1 | 2018 | 49 | 0.140 |
Why?
|
| Ovarian Neoplasms | 1 | 2022 | 462 | 0.130 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2017 | 178 | 0.120 |
Why?
|
| Humans | 14 | 2024 | 131929 | 0.120 |
Why?
|
| Residence Characteristics | 1 | 2017 | 286 | 0.110 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 824 | 0.110 |
Why?
|
| Inflammation | 1 | 2022 | 1519 | 0.110 |
Why?
|
| Autopsy | 1 | 2014 | 111 | 0.110 |
Why?
|
| Fibrosis | 1 | 2014 | 421 | 0.100 |
Why?
|
| Child | 6 | 2022 | 25761 | 0.100 |
Why?
|
| Infant | 3 | 2022 | 13047 | 0.090 |
Why?
|
| Quality Improvement | 1 | 2017 | 699 | 0.090 |
Why?
|
| Genes, p53 | 1 | 2011 | 221 | 0.080 |
Why?
|
| Adolescent | 5 | 2022 | 20535 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2022 | 768 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2014 | 784 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 509 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1949 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2011 | 792 | 0.070 |
Why?
|
| Female | 9 | 2024 | 70586 | 0.070 |
Why?
|
| Mutation | 2 | 2022 | 6226 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 763 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2011 | 933 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 2056 | 0.050 |
Why?
|
| Salivary Glands | 1 | 2021 | 34 | 0.040 |
Why?
|
| Ear, External | 1 | 2021 | 23 | 0.040 |
Why?
|
| Zambia | 1 | 2020 | 23 | 0.040 |
Why?
|
| Neck | 1 | 2021 | 142 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2021 | 389 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 438 | 0.040 |
Why?
|
| Education, Medical, Continuing | 1 | 2018 | 143 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 1693 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2020 | 1233 | 0.030 |
Why?
|
| Neoplasms | 1 | 2011 | 2955 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 3990 | 0.030 |
Why?
|
| Male | 4 | 2024 | 64872 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2021 | 17374 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 1657 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2011 | 124 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2011 | 250 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2011 | 209 | 0.020 |
Why?
|
| Introns | 1 | 2011 | 305 | 0.020 |
Why?
|
| Alleles | 1 | 2011 | 1685 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 21387 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 1422 | 0.020 |
Why?
|
| Middle Aged | 1 | 2024 | 28945 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2019 | 14732 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 31538 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 4751 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 3830 | 0.010 |
Why?
|
| Mice | 1 | 2011 | 18460 | 0.010 |
Why?
|
| Animals | 1 | 2011 | 34782 | 0.000 |
Why?
|